IIT Bombay Study Shows How TB Bacteria Shield Themselves from Antibiotics

New Delhi, Dec 3 (IANS) – A groundbreaking study from the Indian Institute of Technology (IIT) Bombay has revealed how the bacteria Mycobacterium tuberculosis, responsible for tuberculosis (TB), can evade antibiotic treatment and prolong their survival. The research highlights the bacteria’s ability to modify their outer fat coating, providing them with a defense mechanism against commonly used antibiotics.

The Global Burden of Tuberculosis

Despite effective antibiotics and extensive vaccination efforts, tuberculosis remains a significant global health challenge. In 2024, approximately 10.7 million individuals developed TB, leading to 1.23 million deaths worldwide. India, in particular, carries a heavy burden, with over 2.71 million reported cases in the same year.

Key Findings of the Study

The study, published in the journal Chemical Science, focuses on the mechanisms that allow TB bacteria to develop drug tolerance. The researchers conducted experiments under two distinct conditions:

• Active Phase: When the bacteria are rapidly dividing, similar to what occurs during an active infection.
• Late Stage (Dormancy): Mimicking the state of bacteria during latent infections.

Impact of Antibiotics on Bacterial Growth

The research team exposed the bacteria to four commonly used TB drugs: rifabutin, moxifloxacin, amikacin, and clarithromycin. They discovered that:

• The concentration of antibiotics required to inhibit 50% of bacterial growth was two to ten times higher in dormant bacteria compared to active ones.
• This indicates that the same drug effective in the early stages of the disease would need to be administered at much higher doses to affect dormant TB cells.

Understanding Drug Resistance

Professor Shobhna Kapoor from the Department of Chemistry at IIT Bombay emphasized that the observed changes in drug sensitivity were not due to genetic mutations, which are typically associated with antibiotic resistance. Instead, the findings suggest that the bacteria’s dormant state and their membrane characteristics play a crucial role in their ability to resist drugs.

Membrane Composition and Structure

The research team identified over 270 distinct lipid molecules in the bacterial membranes, revealing significant differences between active and dormant cells:

• Active Bacteria: Exhibited loose, fluid membranes.
• Dormant Bacteria: Displayed rigid, tightly ordered membrane structures, indicating a robust defense mechanism.

Implications for Treatment

Professor Kapoor noted that while previous studies have focused on proteins in TB bacteria, the role of lipids has often been overlooked. The new findings suggest that lipids are not merely passive components but actively contribute to the bacteria’s survival and drug resistance.

Barrier to Antibiotic Entry

One critical discovery was that the antibiotic rifabutin could easily penetrate active bacterial cells but struggled to cross the outer membrane of dormant cells. Professor Kapoor explained:

“The rigid outer layer becomes the main barrier. It is the bacterium’s first and strongest line of defense.”

Potential Solutions

Given the findings, the researchers propose that weakening the outer membrane of dormant TB bacteria could enhance the effectiveness of existing antibiotics. Professor Kapoor stated:

“Even old drugs can work better if combined with a molecule that loosens the outer membrane.”

This approach could potentially make bacteria sensitive to antibiotics again, reducing the risk of developing permanent resistance.

Conclusion

The study conducted by IIT Bombay represents a significant advancement in our understanding of how Mycobacterium tuberculosis survives antibiotic treatment. By shifting the focus from genetic mutations to the structural characteristics of bacterial membranes, researchers may pave the way for more effective TB treatments. This research underscores the need for innovative strategies in combating antibiotic resistance, particularly in the context of persistent infections like tuberculosis.

Note: This article is based on research findings and aims to provide insights into the mechanisms of antibiotic resistance in TB bacteria.